ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
3
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Asthma Inhalation Formulation Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-31D18124
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Asthma Inhalation Formulation Market Research Report 2024
BUY CHAPTERS

Global Asthma Inhalation Formulation Market Research Report 2024

Code: QYRE-Auto-31D18124
Report
September 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Recipharm
GSK
Astrazeneca plc
Novartis
Teva Respiratory
Boehringer Ingelheim International
Cipla Ltd
Merck
Lupin Ltd
Perrigo
Viatris
Organon Group

Asthma Inhalation Formulation Market Size

The global Asthma Inhalation Formulation market was valued at US$ 12150 million in 2023 and is anticipated to reach US$ 18930 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.

Asthma Inhalation Formulation Market

Asthma Inhalation Formulation Market

Asthma inhalation formulations are specialized medications designed to deliver drugs directly to the lungs, offering rapid relief and control of asthma symptoms. These formulations typically include bronchodilators, which relax the muscles around the airways, and corticosteroids, which reduce inflammation. Inhalation allows the medication to act quickly and directly on the affected areas with fewer systemic side effects compared to oral or intravenous treatments. Common inhalation devices include metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers, each tailored to different patient needs and preferences. Advances in inhalation technology, such as the development of breath-actuated inhalers and combination inhalers containing multiple drugs, have improved the management of asthma by enhancing drug delivery and patient adherence.
North American market for Asthma Inhalation Formulation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Asthma Inhalation Formulation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Asthma Inhalation Formulation include Recipharm AB, GSK, AstraZeneca, Novartis, Teva Respiratory, Boehringer Ingelheim International, Cipla, Merck, Lupin, Perrigo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Asthma Inhalation Formulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Inhalation Formulation.
The Asthma Inhalation Formulation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Asthma Inhalation Formulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma Inhalation Formulation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Asthma Inhalation Formulation Market Report

Report Metric Details
Report Name Asthma Inhalation Formulation Market
Accounted market size in 2023 US$ 12150 million
Forecasted market size in 2030 US$ 18930 million
CAGR 6.5%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Corticosteroids
  • Bronchodilators
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Recipharm AB, GSK, AstraZeneca, Novartis, Teva Respiratory, Boehringer Ingelheim International, Cipla, Merck, Lupin, Perrigo, Viatris, Organon Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Asthma Inhalation Formulation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Asthma Inhalation Formulation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Asthma Inhalation Formulation Market growing?

Ans: The Asthma Inhalation Formulation Market witnessing a CAGR of 6.5% during the forecast period 2024-2030.

What is the Asthma Inhalation Formulation Market size in 2030?

Ans: The Asthma Inhalation Formulation Market size in 2030 will be US$ 18930 million.

Who are the main players in the Asthma Inhalation Formulation Market report?

Ans: The main players in the Asthma Inhalation Formulation Market are Recipharm AB, GSK, AstraZeneca, Novartis, Teva Respiratory, Boehringer Ingelheim International, Cipla, Merck, Lupin, Perrigo, Viatris, Organon Group

What are the Application segmentation covered in the Asthma Inhalation Formulation Market report?

Ans: The Applications covered in the Asthma Inhalation Formulation Market report are Hospitals, Specialty Clinics, Retail Pharmacy Chains, Online Pharmacies, Other

What are the Type segmentation covered in the Asthma Inhalation Formulation Market report?

Ans: The Types covered in the Asthma Inhalation Formulation Market report are Corticosteroids, Bronchodilators

Recommended Reports

Asthma Drug Markets

Inhalers & Devices

Drug Delivery Solutions

1 Asthma Inhalation Formulation Market Overview
1.1 Product Definition
1.2 Asthma Inhalation Formulation by Type
1.2.1 Global Asthma Inhalation Formulation Market Value Comparison by Type (2024-2030)
1.2.2 Corticosteroids
1.2.3 Bronchodilators
1.3 Asthma Inhalation Formulation by Application
1.3.1 Global Asthma Inhalation Formulation Market Value by Application (2024-2030)
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Retail Pharmacy Chains
1.3.5 Online Pharmacies
1.3.6 Other
1.4 Global Asthma Inhalation Formulation Market Size Estimates and Forecasts
1.4.1 Global Asthma Inhalation Formulation Revenue 2019-2030
1.4.2 Global Asthma Inhalation Formulation Sales 2019-2030
1.4.3 Global Asthma Inhalation Formulation Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Asthma Inhalation Formulation Market Competition by Manufacturers
2.1 Global Asthma Inhalation Formulation Sales Market Share by Manufacturers (2019-2024)
2.2 Global Asthma Inhalation Formulation Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Asthma Inhalation Formulation Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Asthma Inhalation Formulation, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Asthma Inhalation Formulation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Asthma Inhalation Formulation, Product Type & Application
2.7 Global Key Manufacturers of Asthma Inhalation Formulation, Date of Enter into This Industry
2.8 Global Asthma Inhalation Formulation Market Competitive Situation and Trends
2.8.1 Global Asthma Inhalation Formulation Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Asthma Inhalation Formulation Players Market Share by Revenue
2.8.3 Global Asthma Inhalation Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Asthma Inhalation Formulation Market Scenario by Region
3.1 Global Asthma Inhalation Formulation Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Asthma Inhalation Formulation Sales by Region: 2019-2030
3.2.1 Global Asthma Inhalation Formulation Sales by Region: 2019-2024
3.2.2 Global Asthma Inhalation Formulation Sales by Region: 2025-2030
3.3 Global Asthma Inhalation Formulation Revenue by Region: 2019-2030
3.3.1 Global Asthma Inhalation Formulation Revenue by Region: 2019-2024
3.3.2 Global Asthma Inhalation Formulation Revenue by Region: 2025-2030
3.4 North America Asthma Inhalation Formulation Market Facts & Figures by Country
3.4.1 North America Asthma Inhalation Formulation Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Asthma Inhalation Formulation Sales by Country (2019-2030)
3.4.3 North America Asthma Inhalation Formulation Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Asthma Inhalation Formulation Market Facts & Figures by Country
3.5.1 Europe Asthma Inhalation Formulation Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Asthma Inhalation Formulation Sales by Country (2019-2030)
3.5.3 Europe Asthma Inhalation Formulation Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Asthma Inhalation Formulation Market Facts & Figures by Region
3.6.1 Asia Pacific Asthma Inhalation Formulation Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Asthma Inhalation Formulation Sales by Region (2019-2030)
3.6.3 Asia Pacific Asthma Inhalation Formulation Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Asthma Inhalation Formulation Market Facts & Figures by Country
3.7.1 Latin America Asthma Inhalation Formulation Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Asthma Inhalation Formulation Sales by Country (2019-2030)
3.7.3 Latin America Asthma Inhalation Formulation Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Asthma Inhalation Formulation Market Facts & Figures by Country
3.8.1 Middle East and Africa Asthma Inhalation Formulation Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Asthma Inhalation Formulation Sales by Country (2019-2030)
3.8.3 Middle East and Africa Asthma Inhalation Formulation Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Asthma Inhalation Formulation Sales by Type (2019-2030)
4.1.1 Global Asthma Inhalation Formulation Sales by Type (2019-2024)
4.1.2 Global Asthma Inhalation Formulation Sales by Type (2025-2030)
4.1.3 Global Asthma Inhalation Formulation Sales Market Share by Type (2019-2030)
4.2 Global Asthma Inhalation Formulation Revenue by Type (2019-2030)
4.2.1 Global Asthma Inhalation Formulation Revenue by Type (2019-2024)
4.2.2 Global Asthma Inhalation Formulation Revenue by Type (2025-2030)
4.2.3 Global Asthma Inhalation Formulation Revenue Market Share by Type (2019-2030)
4.3 Global Asthma Inhalation Formulation Price by Type (2019-2030)
5 Segment by Application
5.1 Global Asthma Inhalation Formulation Sales by Application (2019-2030)
5.1.1 Global Asthma Inhalation Formulation Sales by Application (2019-2024)
5.1.2 Global Asthma Inhalation Formulation Sales by Application (2025-2030)
5.1.3 Global Asthma Inhalation Formulation Sales Market Share by Application (2019-2030)
5.2 Global Asthma Inhalation Formulation Revenue by Application (2019-2030)
5.2.1 Global Asthma Inhalation Formulation Revenue by Application (2019-2024)
5.2.2 Global Asthma Inhalation Formulation Revenue by Application (2025-2030)
5.2.3 Global Asthma Inhalation Formulation Revenue Market Share by Application (2019-2030)
5.3 Global Asthma Inhalation Formulation Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Recipharm AB
6.1.1 Recipharm AB Company Information
6.1.2 Recipharm AB Description and Business Overview
6.1.3 Recipharm AB Asthma Inhalation Formulation Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Recipharm AB Asthma Inhalation Formulation Product Portfolio
6.1.5 Recipharm AB Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Asthma Inhalation Formulation Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Asthma Inhalation Formulation Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Asthma Inhalation Formulation Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Asthma Inhalation Formulation Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Asthma Inhalation Formulation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Asthma Inhalation Formulation Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Teva Respiratory
6.5.1 Teva Respiratory Company Information
6.5.2 Teva Respiratory Description and Business Overview
6.5.3 Teva Respiratory Asthma Inhalation Formulation Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Respiratory Asthma Inhalation Formulation Product Portfolio
6.5.5 Teva Respiratory Recent Developments/Updates
6.6 Boehringer Ingelheim International
6.6.1 Boehringer Ingelheim International Company Information
6.6.2 Boehringer Ingelheim International Description and Business Overview
6.6.3 Boehringer Ingelheim International Asthma Inhalation Formulation Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boehringer Ingelheim International Asthma Inhalation Formulation Product Portfolio
6.6.5 Boehringer Ingelheim International Recent Developments/Updates
6.7 Cipla
6.7.1 Cipla Company Information
6.7.2 Cipla Description and Business Overview
6.7.3 Cipla Asthma Inhalation Formulation Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Cipla Asthma Inhalation Formulation Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Merck
6.8.1 Merck Company Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Asthma Inhalation Formulation Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merck Asthma Inhalation Formulation Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Lupin
6.9.1 Lupin Company Information
6.9.2 Lupin Description and Business Overview
6.9.3 Lupin Asthma Inhalation Formulation Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Lupin Asthma Inhalation Formulation Product Portfolio
6.9.5 Lupin Recent Developments/Updates
6.10 Perrigo
6.10.1 Perrigo Company Information
6.10.2 Perrigo Description and Business Overview
6.10.3 Perrigo Asthma Inhalation Formulation Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Perrigo Asthma Inhalation Formulation Product Portfolio
6.10.5 Perrigo Recent Developments/Updates
6.11 Viatris
6.11.1 Viatris Company Information
6.11.2 Viatris Description and Business Overview
6.11.3 Viatris Asthma Inhalation Formulation Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Viatris Asthma Inhalation Formulation Product Portfolio
6.11.5 Viatris Recent Developments/Updates
6.12 Organon Group
6.12.1 Organon Group Company Information
6.12.2 Organon Group Description and Business Overview
6.12.3 Organon Group Asthma Inhalation Formulation Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Organon Group Asthma Inhalation Formulation Product Portfolio
6.12.5 Organon Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Asthma Inhalation Formulation Industry Chain Analysis
7.2 Asthma Inhalation Formulation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Asthma Inhalation Formulation Production Mode & Process
7.4 Asthma Inhalation Formulation Sales and Marketing
7.4.1 Asthma Inhalation Formulation Sales Channels
7.4.2 Asthma Inhalation Formulation Distributors
7.5 Asthma Inhalation Formulation Customers
8 Asthma Inhalation Formulation Market Dynamics
8.1 Asthma Inhalation Formulation Industry Trends
8.2 Asthma Inhalation Formulation Market Drivers
8.3 Asthma Inhalation Formulation Market Challenges
8.4 Asthma Inhalation Formulation Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Recipharm
GSK
Astrazeneca plc
Novartis
Teva Respiratory
Boehringer Ingelheim International
Cipla Ltd
Merck
Lupin Ltd
Perrigo
Viatris
Organon Group
List of Tables
 Table 1. Global Asthma Inhalation Formulation Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Asthma Inhalation Formulation Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Asthma Inhalation Formulation Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Asthma Inhalation Formulation Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Asthma Inhalation Formulation Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Asthma Inhalation Formulation Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Asthma Inhalation Formulation Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Asthma Inhalation Formulation Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Asthma Inhalation Formulation, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Asthma Inhalation Formulation, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Asthma Inhalation Formulation, Product Type & Application
 Table 12. Global Key Manufacturers of Asthma Inhalation Formulation, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Asthma Inhalation Formulation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Inhalation Formulation as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Asthma Inhalation Formulation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Asthma Inhalation Formulation Sales by Region (2019-2024) & (K Units)
 Table 18. Global Asthma Inhalation Formulation Sales Market Share by Region (2019-2024)
 Table 19. Global Asthma Inhalation Formulation Sales by Region (2025-2030) & (K Units)
 Table 20. Global Asthma Inhalation Formulation Sales Market Share by Region (2025-2030)
 Table 21. Global Asthma Inhalation Formulation Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Asthma Inhalation Formulation Revenue Market Share by Region (2019-2024)
 Table 23. Global Asthma Inhalation Formulation Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Asthma Inhalation Formulation Revenue Market Share by Region (2025-2030)
 Table 25. North America Asthma Inhalation Formulation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Asthma Inhalation Formulation Sales by Country (2019-2024) & (K Units)
 Table 27. North America Asthma Inhalation Formulation Sales by Country (2025-2030) & (K Units)
 Table 28. North America Asthma Inhalation Formulation Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Asthma Inhalation Formulation Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Asthma Inhalation Formulation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Asthma Inhalation Formulation Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Asthma Inhalation Formulation Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Asthma Inhalation Formulation Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Asthma Inhalation Formulation Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Asthma Inhalation Formulation Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Asthma Inhalation Formulation Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Asthma Inhalation Formulation Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Asthma Inhalation Formulation Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Asthma Inhalation Formulation Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Asthma Inhalation Formulation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Asthma Inhalation Formulation Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Asthma Inhalation Formulation Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Asthma Inhalation Formulation Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Asthma Inhalation Formulation Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Asthma Inhalation Formulation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Asthma Inhalation Formulation Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Asthma Inhalation Formulation Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Asthma Inhalation Formulation Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Asthma Inhalation Formulation Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Asthma Inhalation Formulation Sales (K Units) by Type (2019-2024)
 Table 51. Global Asthma Inhalation Formulation Sales (K Units) by Type (2025-2030)
 Table 52. Global Asthma Inhalation Formulation Sales Market Share by Type (2019-2024)
 Table 53. Global Asthma Inhalation Formulation Sales Market Share by Type (2025-2030)
 Table 54. Global Asthma Inhalation Formulation Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Asthma Inhalation Formulation Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Asthma Inhalation Formulation Revenue Market Share by Type (2019-2024)
 Table 57. Global Asthma Inhalation Formulation Revenue Market Share by Type (2025-2030)
 Table 58. Global Asthma Inhalation Formulation Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Asthma Inhalation Formulation Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Asthma Inhalation Formulation Sales (K Units) by Application (2019-2024)
 Table 61. Global Asthma Inhalation Formulation Sales (K Units) by Application (2025-2030)
 Table 62. Global Asthma Inhalation Formulation Sales Market Share by Application (2019-2024)
 Table 63. Global Asthma Inhalation Formulation Sales Market Share by Application (2025-2030)
 Table 64. Global Asthma Inhalation Formulation Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Asthma Inhalation Formulation Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Asthma Inhalation Formulation Revenue Market Share by Application (2019-2024)
 Table 67. Global Asthma Inhalation Formulation Revenue Market Share by Application (2025-2030)
 Table 68. Global Asthma Inhalation Formulation Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Asthma Inhalation Formulation Price (US$/Unit) by Application (2025-2030)
 Table 70. Recipharm AB Company Information
 Table 71. Recipharm AB Description and Business Overview
 Table 72. Recipharm AB Asthma Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Recipharm AB Asthma Inhalation Formulation Product
 Table 74. Recipharm AB Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Asthma Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. GSK Asthma Inhalation Formulation Product
 Table 79. GSK Recent Developments/Updates
 Table 80. AstraZeneca Company Information
 Table 81. AstraZeneca Description and Business Overview
 Table 82. AstraZeneca Asthma Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. AstraZeneca Asthma Inhalation Formulation Product
 Table 84. AstraZeneca Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Asthma Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Novartis Asthma Inhalation Formulation Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Teva Respiratory Company Information
 Table 91. Teva Respiratory Description and Business Overview
 Table 92. Teva Respiratory Asthma Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Teva Respiratory Asthma Inhalation Formulation Product
 Table 94. Teva Respiratory Recent Developments/Updates
 Table 95. Boehringer Ingelheim International Company Information
 Table 96. Boehringer Ingelheim International Description and Business Overview
 Table 97. Boehringer Ingelheim International Asthma Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Boehringer Ingelheim International Asthma Inhalation Formulation Product
 Table 99. Boehringer Ingelheim International Recent Developments/Updates
 Table 100. Cipla Company Information
 Table 101. Cipla Description and Business Overview
 Table 102. Cipla Asthma Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Cipla Asthma Inhalation Formulation Product
 Table 104. Cipla Recent Developments/Updates
 Table 105. Merck Company Information
 Table 106. Merck Description and Business Overview
 Table 107. Merck Asthma Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Merck Asthma Inhalation Formulation Product
 Table 109. Merck Recent Developments/Updates
 Table 110. Lupin Company Information
 Table 111. Lupin Description and Business Overview
 Table 112. Lupin Asthma Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Lupin Asthma Inhalation Formulation Product
 Table 114. Lupin Recent Developments/Updates
 Table 115. Perrigo Company Information
 Table 116. Perrigo Description and Business Overview
 Table 117. Perrigo Asthma Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Perrigo Asthma Inhalation Formulation Product
 Table 119. Perrigo Recent Developments/Updates
 Table 120. Viatris Company Information
 Table 121. Viatris Description and Business Overview
 Table 122. Viatris Asthma Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Viatris Asthma Inhalation Formulation Product
 Table 124. Viatris Recent Developments/Updates
 Table 125. Organon Group Company Information
 Table 126. Organon Group Description and Business Overview
 Table 127. Organon Group Asthma Inhalation Formulation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Organon Group Asthma Inhalation Formulation Product
 Table 129. Organon Group Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Asthma Inhalation Formulation Distributors List
 Table 133. Asthma Inhalation Formulation Customers List
 Table 134. Asthma Inhalation Formulation Market Trends
 Table 135. Asthma Inhalation Formulation Market Drivers
 Table 136. Asthma Inhalation Formulation Market Challenges
 Table 137. Asthma Inhalation Formulation Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Asthma Inhalation Formulation
 Figure 2. Global Asthma Inhalation Formulation Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Asthma Inhalation Formulation Market Share by Type: 2023 & 2030
 Figure 4. Corticosteroids Product Picture
 Figure 5. Bronchodilators Product Picture
 Figure 6. Global Asthma Inhalation Formulation Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Asthma Inhalation Formulation Market Share by Application: 2023 & 2030
 Figure 8. Hospitals
 Figure 9. Specialty Clinics
 Figure 10. Retail Pharmacy Chains
 Figure 11. Online Pharmacies
 Figure 12. Other
 Figure 13. Global Asthma Inhalation Formulation Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Asthma Inhalation Formulation Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Asthma Inhalation Formulation Sales (2019-2030) & (K Units)
 Figure 16. Global Asthma Inhalation Formulation Average Price (US$/Unit) & (2019-2030)
 Figure 17. Asthma Inhalation Formulation Report Years Considered
 Figure 18. Asthma Inhalation Formulation Sales Share by Manufacturers in 2023
 Figure 19. Global Asthma Inhalation Formulation Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Asthma Inhalation Formulation Players: Market Share by Revenue in Asthma Inhalation Formulation in 2023
 Figure 21. Asthma Inhalation Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Asthma Inhalation Formulation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Asthma Inhalation Formulation Sales Market Share by Country (2019-2030)
 Figure 24. North America Asthma Inhalation Formulation Revenue Market Share by Country (2019-2030)
 Figure 25. United States Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Asthma Inhalation Formulation Sales Market Share by Country (2019-2030)
 Figure 28. Europe Asthma Inhalation Formulation Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Asthma Inhalation Formulation Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Asthma Inhalation Formulation Revenue Market Share by Region (2019-2030)
 Figure 36. China Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Asthma Inhalation Formulation Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Asthma Inhalation Formulation Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Asthma Inhalation Formulation Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Asthma Inhalation Formulation Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Asthma Inhalation Formulation by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Asthma Inhalation Formulation by Type (2019-2030)
 Figure 55. Global Asthma Inhalation Formulation Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Asthma Inhalation Formulation by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Asthma Inhalation Formulation by Application (2019-2030)
 Figure 58. Global Asthma Inhalation Formulation Price (US$/Unit) by Application (2019-2030)
 Figure 59. Asthma Inhalation Formulation Value Chain
 Figure 60. Asthma Inhalation Formulation Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Corticosteroids Inhalation Formulation Market Research Report 2024
Global Inhalation Drug Delivery Devices Market Research Report 2024
Global Inhaler Devices for Respiratory Medicines Market Research Report 2024
Global Dry Powder Inhalation Capsules Market Research Report 2024
Global Asthma Nebulizer Market Research Report 2025
Global Inhalation and Nasal Drug Delivery Devices Market Research Report 2024
Global Inhalation Drug Delivery Device Market Research Report 2024
Global Inhaled Asthma Medications Market Research Report 2024
Global Pressurized Metered dose Inhaler Market Research Report 2025
Global Inhaled Generic Drugs Market Research Report 2024
Global Inhaler Devices Market Insights Forecast to 2030
Air Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Asthma Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inhalation Capsules Market Insights Forecast to 2030
Global Inhalation Therapy Nebulizer Market Insights Forecast to 2030
Global Dry Powder Inhalation Delivery System Market Research Report 2024
Global Breath actuated Inhaler Market Research Report 2025
Global Dry Powder Inhalation Medication Market Research Report 2024
Global COPD and Asthma Drug Devices Market Insights Forecast to 2030
Global Adult Dry Powder Inhalers Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions